[
  {
    "ts": "2025-11-06T15:00:00+00:00",
    "headline": "Life Sciences, TechBio, and Investment Leaders at Demy-Colton’s BioFuture™ 2025 Suggest Health and Biotech Sectors Show Signs of New Life",
    "summary": "NEW YORK, November 06, 2025--Life Sciences, TechBio, and Investment Leaders at Demy-Colton’s BioFuture™ 2025 Suggest Health and Biotech Sectors Show Signs of New Life",
    "url": "https://finance.yahoo.com/news/life-sciences-techbio-investment-leaders-150000704.html",
    "source": "Business Wire",
    "provider": "yfinance",
    "raw": {
      "id": "0bb65a23-2222-3e01-b59a-fe9e7edf8093",
      "content": {
        "id": "0bb65a23-2222-3e01-b59a-fe9e7edf8093",
        "contentType": "STORY",
        "title": "Life Sciences, TechBio, and Investment Leaders at Demy-Colton’s BioFuture™ 2025 Suggest Health and Biotech Sectors Show Signs of New Life",
        "description": "",
        "summary": "NEW YORK, November 06, 2025--Life Sciences, TechBio, and Investment Leaders at Demy-Colton’s BioFuture™ 2025 Suggest Health and Biotech Sectors Show Signs of New Life",
        "pubDate": "2025-11-06T15:00:00Z",
        "displayTime": "2025-11-06T15:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/business-wire.com/7164d9d88c4aa04076e65b5d7085fec6",
          "originalWidth": 480,
          "originalHeight": 251,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/MrmOHkCJXMQxW9RdhnD5ww--~B/aD0yNTE7dz00ODA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/7164d9d88c4aa04076e65b5d7085fec6.cf.webp",
              "width": 480,
              "height": 251,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/3Kift4PF6TEkUtfq57L7og--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/7164d9d88c4aa04076e65b5d7085fec6.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Business Wire",
          "url": "http://www.businesswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/life-sciences-techbio-investment-leaders-150000704.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/life-sciences-techbio-investment-leaders-150000704.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "REGN"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-06T21:00:00+00:00",
    "headline": "Intellia Therapeutics Announces Third Quarter 2025 Financial Results and Recent Updates",
    "summary": "Awaiting FDA clinical hold letter on MAGNITUDE and MAGNITUDE-2 clinical trials of nex-zPresenting longer-term Phase 1 clinical data of nex-z for ATTR-CM on November 10 at AHA 2025; previously published longer-term Phase 1 clinical data for nex-z for ATTRv-PN in New England Journal of MedicineCompleted enrollment in Phase 3 HAELO clinical trial of lonvo-z for HAE; topline data expected by mid-2026 with potential U.S. commercial launch in 1H27Presenting longer-term Phase 1/2 clinical data of lonvo",
    "url": "https://finance.yahoo.com/news/intellia-therapeutics-announces-third-quarter-210000621.html",
    "source": "GlobeNewswire",
    "provider": "yfinance",
    "raw": {
      "id": "c3570060-f008-374a-9752-4d552694c971",
      "content": {
        "id": "c3570060-f008-374a-9752-4d552694c971",
        "contentType": "STORY",
        "title": "Intellia Therapeutics Announces Third Quarter 2025 Financial Results and Recent Updates",
        "description": "",
        "summary": "Awaiting FDA clinical hold letter on MAGNITUDE and MAGNITUDE-2 clinical trials of nex-zPresenting longer-term Phase 1 clinical data of nex-z for ATTR-CM on November 10 at AHA 2025; previously published longer-term Phase 1 clinical data for nex-z for ATTRv-PN in New England Journal of MedicineCompleted enrollment in Phase 3 HAELO clinical trial of lonvo-z for HAE; topline data expected by mid-2026 with potential U.S. commercial launch in 1H27Presenting longer-term Phase 1/2 clinical data of lonvo",
        "pubDate": "2025-11-06T21:00:00Z",
        "displayTime": "2025-11-06T21:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/globenewswire.com/cc90f97da0ab89e42cba6497d0363207",
          "originalWidth": 699,
          "originalHeight": 350,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/riqI5T.7geNxe1INtuNDWA--~B/aD0zNTA7dz02OTk7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/cc90f97da0ab89e42cba6497d0363207.cf.webp",
              "width": 699,
              "height": 350,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/N3lOy8p3R2lvpjEyEDLcdw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/cc90f97da0ab89e42cba6497d0363207.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "GlobeNewswire",
          "url": "https://www.globenewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/intellia-therapeutics-announces-third-quarter-210000621.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/intellia-therapeutics-announces-third-quarter-210000621.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "NTLA"
            },
            {
              "symbol": "REGN"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]